238 related articles for article (PubMed ID: 31171783)
21. Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy.
Yue M; Hanna A; Wilson J; Roder H; Janus C
Neurobiol Aging; 2011 Apr; 32(4):590-603. PubMed ID: 19427061
[TBL] [Abstract][Full Text] [Related]
22. Developmental Pathogenicity of 4-Repeat Human Tau Is Lost with the P301L Mutation in Genetically Matched Tau-Transgenic Mice.
Gamache JE; Kemper L; Steuer E; Leinonen-Wright K; Choquette JM; Hlynialuk C; Benzow K; Vossel KA; Xia W; Koob MD; Ashe KH
J Neurosci; 2020 Jan; 40(1):220-236. PubMed ID: 31685653
[TBL] [Abstract][Full Text] [Related]
23. Extracellular Vesicles Isolated from the Brains of rTg4510 Mice Seed Tau Protein Aggregation in a Threshold-dependent Manner.
Polanco JC; Scicluna BJ; Hill AF; Götz J
J Biol Chem; 2016 Jun; 291(24):12445-12466. PubMed ID: 27030011
[TBL] [Abstract][Full Text] [Related]
24. Synaptic alterations in the rTg4510 mouse model of tauopathy.
Kopeikina KJ; Polydoro M; Tai HC; Yaeger E; Carlson GA; Pitstick R; Hyman BT; Spires-Jones TL
J Comp Neurol; 2013 Apr; 521(6):1334-53. PubMed ID: 23047530
[TBL] [Abstract][Full Text] [Related]
25. Altered function of hippocampal CA1 pyramidal neurons in the rTg4510 mouse model of tauopathy.
Dalby NO; Volbracht C; Helboe L; Larsen PH; Jensen HS; Egebjerg J; Elvang AB
J Alzheimers Dis; 2014; 40(2):429-42. PubMed ID: 24448785
[TBL] [Abstract][Full Text] [Related]
26. Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model.
Jul P; Volbracht C; de Jong IE; Helboe L; Elvang AB; Pedersen JT
J Alzheimers Dis; 2016; 49(3):783-95. PubMed ID: 26519432
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration.
Holton CM; Hanley N; Shanks E; Oxley P; McCarthy A; Eastwood BJ; Murray TK; Nickerson A; Wafford KA
Alzheimers Res Ther; 2020 Jul; 12(1):84. PubMed ID: 32669112
[TBL] [Abstract][Full Text] [Related]
28. Pazopanib Reduces Phosphorylated Tau Levels and Alters Astrocytes in a Mouse Model of Tauopathy.
Javidnia M; Hebron ML; Xin Y; Kinney NG; Moussa CE
J Alzheimers Dis; 2017; 60(2):461-481. PubMed ID: 28869476
[TBL] [Abstract][Full Text] [Related]
29. Sustained Arginase 1 Expression Modulates Pathological Tau Deposits in a Mouse Model of Tauopathy.
Hunt JB; Nash KR; Placides D; Moran P; Selenica ML; Abuqalbeen F; Ratnasamy K; Slouha N; Rodriguez-Ospina S; Savlia M; Ranaweera Y; Reid P; Dickey CA; Uricia R; Yang CG; Sandusky LA; Gordon MN; Morgan D; Lee DC
J Neurosci; 2015 Nov; 35(44):14842-60. PubMed ID: 26538654
[TBL] [Abstract][Full Text] [Related]
30. In vivo functional brain mapping in a conditional mouse model of human tauopathy (tauP301L) reveals reduced neural activity in memory formation structures.
Perez PD; Hall G; Kimura T; Ren Y; Bailey RM; Lewis J; Febo M; Sahara N
Mol Neurodegener; 2013 Feb; 8():9. PubMed ID: 23379588
[TBL] [Abstract][Full Text] [Related]
31. Human tau expression reduces adult neurogenesis in a mouse model of tauopathy.
Komuro Y; Xu G; Bhaskar K; Lamb BT
Neurobiol Aging; 2015 Jun; 36(6):2034-42. PubMed ID: 25863528
[TBL] [Abstract][Full Text] [Related]
32. PE859, a novel tau aggregation inhibitor, reduces aggregated tau and prevents onset and progression of neural dysfunction in vivo.
Okuda M; Hijikuro I; Fujita Y; Wu X; Nakayama S; Sakata Y; Noguchi Y; Ogo M; Akasofu S; Ito Y; Soeda Y; Tsuchiya N; Tanaka N; Takahashi T; Sugimoto H
PLoS One; 2015; 10(2):e0117511. PubMed ID: 25659102
[TBL] [Abstract][Full Text] [Related]
33. Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy.
Blair LJ; Frauen HD; Zhang B; Nordhues BA; Bijan S; Lin YC; Zamudio F; Hernandez LD; Sabbagh JJ; Selenica ML; Dickey CA
Acta Neuropathol Commun; 2015 Jan; 3():8. PubMed ID: 25775028
[TBL] [Abstract][Full Text] [Related]
34. Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model.
Ando K; Leroy K; Heraud C; Kabova A; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP
Biochem Soc Trans; 2010 Aug; 38(4):1001-5. PubMed ID: 20658993
[TBL] [Abstract][Full Text] [Related]
35. Orexin 2 receptor antagonism sex-dependently improves sleep/wakefulness and cognitive performance in tau transgenic mice.
Keenan RJ; Daykin H; Metha J; Cornthwaite-Duncan L; Wright DK; Clarke K; Oberrauch S; Brian M; Stephenson S; Nowell CJ; Allocca G; Barnham KJ; Hoyer D; Jacobson LH
Br J Pharmacol; 2024 Jan; 181(1):87-106. PubMed ID: 37553894
[TBL] [Abstract][Full Text] [Related]
36. The CNS in inbred transgenic models of 4-repeat Tauopathy develops consistent tau seeding capacity yet focal and diverse patterns of protein deposition.
Eskandari-Sedighi G; Daude N; Gapeshina H; Sanders DW; Kamali-Jamil R; Yang J; Shi B; Wille H; Ghetti B; Diamond MI; Janus C; Westaway D
Mol Neurodegener; 2017 Oct; 12(1):72. PubMed ID: 28978354
[TBL] [Abstract][Full Text] [Related]
37. Bidirectional interplay of HSF1 degradation and UPR activation promotes tau hyperphosphorylation.
Kim E; Sakata K; Liao FF
PLoS Genet; 2017 Jul; 13(7):e1006849. PubMed ID: 28678786
[TBL] [Abstract][Full Text] [Related]
38. In Vivo Visualization of Tau Accumulation, Microglial Activation, and Brain Atrophy in a Mouse Model of Tauopathy rTg4510.
Ishikawa A; Tokunaga M; Maeda J; Minamihisamatsu T; Shimojo M; Takuwa H; Ono M; Ni R; Hirano S; Kuwabara S; Ji B; Zhang MR; Aoki I; Suhara T; Higuchi M; Sahara N
J Alzheimers Dis; 2018; 61(3):1037-1052. PubMed ID: 29332041
[TBL] [Abstract][Full Text] [Related]
39. Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model.
Shimojo M; Takuwa H; Takado Y; Tokunaga M; Tsukamoto S; Minatohara K; Ono M; Seki C; Maeda J; Urushihata T; Minamihisamatsu T; Aoki I; Kawamura K; Zhang MR; Suhara T; Sahara N; Higuchi M
J Neurosci; 2020 Apr; 40(17):3491-3501. PubMed ID: 32265258
[TBL] [Abstract][Full Text] [Related]
40. A farnesyltransferase inhibitor activates lysosomes and reduces tau pathology in mice with tauopathy.
Hernandez I; Luna G; Rauch JN; Reis SA; Giroux M; Karch CM; Boctor D; Sibih YE; Storm NJ; Diaz A; Kaushik S; Zekanowski C; Kang AA; Hinman CR; Cerovac V; Guzman E; Zhou H; Haggarty SJ; Goate AM; Fisher SK; Cuervo AM; Kosik KS
Sci Transl Med; 2019 Mar; 11(485):. PubMed ID: 30918111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
